Krabbe's Leukodystrophy

Treatment No. : RD0601
Dosage & Instructions: 15 drops in 15 ml of plain water twice a day, mornings and evenings after meal.
Composition:
Absinthium D3
Artemisia vulg D2
Collinsonia canad D3
Nux vomica D4
Lupulinum D2
Mentha piperita TM
Acorus calamus TM
Treatment Type:
This remedy is a symptomatic treatment. A symptomatic treatment cannot eliminate the disease from its root but is able to considerably improve the patient's condition by easing his or her symptoms.
Contra-indications: None established
Special Instructions: Whereas this remedy can be safely used by teenagers, its use has not been evaluated in children under 12 years of age. Please do not administer to children under this age.
Storage: Store in a cool and dry place
Precautions: Keep away from the reach of children
Standard Packaging : 90 ml Drops

Order Online:

One 90 ml bottle for $79.99
Two 90 ml bottles for $129.99

 

Condition Overview:

Krabbe's Leukodystrophy is a rare inherited lipid storage disorder caused by a deficiency of the enzyme galactocerebrosidase (GALC), which is necessary for the breakdown (metabolism) of the sphingolipids galactosylceremide and psychosine. Failure to break down these sphingolipids results in degeneration of the myelin sheath surrounding nerves in the brain (demyelination). Characteristic globoid cells appear in affected areas of the brain. This metabolic disorder is characterized by progressive neurological dysfunction such as mental retardation, paralysis, blindness, deafness and paralysis of certain facial muscles (pseudobulbar palsy). Krabbe’s Leukodystrophy is inherited as an autosomal recessive trait.
.